263 related articles for article (PubMed ID: 30165051)
1. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
Jodal HC; Løberg M; Holme Ø; Adami HO; Bretthauer M; Emilsson L; Ransohoff DF; Hoff G; Kalager M
Gastroenterology; 2018 Dec; 155(6):1787-1794.e3. PubMed ID: 30165051
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.
Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Lekven J; Schneede J; Tveit KM; Vatn M; Ursin G; Hoff G;
Ann Intern Med; 2018 Jun; 168(11):775-782. PubMed ID: 29710125
[TBL] [Abstract][Full Text] [Related]
3. Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
Doroudi M; Schoen RE; Pinsky PF
Cancer; 2017 Dec; 123(24):4815-4822. PubMed ID: 28976536
[TBL] [Abstract][Full Text] [Related]
4. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Schneede J; Tveit KM; Hoff G
JAMA; 2014 Aug; 312(6):606-15. PubMed ID: 25117129
[TBL] [Abstract][Full Text] [Related]
5. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
6. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.
Segnan N; Armaroli P; Bonelli L; Risio M; Sciallero S; Zappa M; Andreoni B; Arrigoni A; Bisanti L; Casella C; Crosta C; Falcini F; Ferrero F; Giacomin A; Giuliani O; Santarelli A; Visioli CB; Zanetti R; Atkin WS; Senore C;
J Natl Cancer Inst; 2011 Sep; 103(17):1310-22. PubMed ID: 21852264
[TBL] [Abstract][Full Text] [Related]
7. Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results.
Buskermolen M; Gini A; Naber SK; Toes-Zoutendijk E; de Koning HJ; Lansdorp-Vogelaar I
Med Decis Making; 2018 Nov; 38(8):917-929. PubMed ID: 30343626
[TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.
Randel KR; Schult AL; Botteri E; Hoff G; Bretthauer M; Ursin G; Natvig E; Berstad P; Jørgensen A; Sandvei PK; Olsen ME; Frigstad SO; Darre-Næss O; Norvard ER; Bolstad N; Kørner H; Wibe A; Wensaas KA; de Lange T; Holme Ø
Gastroenterology; 2021 Mar; 160(4):1085-1096.e5. PubMed ID: 33227280
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with symptom- and screening-detected colorectal cancer.
Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
[TBL] [Abstract][Full Text] [Related]
10. Assessing generalizability of the findings of sigmoidoscopy screening trials: the case of SCORE trial.
Senore C; Bonelli L; Sciallero S; Casella C; Santarelli A; Armaroli P; Zanetti R; Segnan N
J Natl Cancer Inst; 2015 Jan; 107(1):385. PubMed ID: 25492939
[TBL] [Abstract][Full Text] [Related]
11. Screening colonoscopy versus sigmoidoscopy: implications of a negative examination for cancer prevention and racial disparities in average-risk patients.
Wu BU; Longstreth GF; Ngor EW
Gastrointest Endosc; 2014 Nov; 80(5):852-61.e1-2. PubMed ID: 24814774
[TBL] [Abstract][Full Text] [Related]
12. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H
PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176
[TBL] [Abstract][Full Text] [Related]
13. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer.
Schoen RE; Razzak A; Yu KJ; Berndt SI; Firl K; Riley TL; Pinsky PF
Gastroenterology; 2015 Nov; 149(6):1438-1445.e1. PubMed ID: 26255045
[TBL] [Abstract][Full Text] [Related]
14. Increased odds of interval left-sided colorectal cancer after flexible sigmoidoscopy compared with colonoscopy in older patients in the United States: a population-based analysis of the SEER-Medicare linked database, 2001-2005.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Mayo Clin Proc; 2013 May; 88(5):471-8. PubMed ID: 23562347
[TBL] [Abstract][Full Text] [Related]
15. Risk of colorectal cancer after colonoscopy compared with flexible sigmoidoscopy or no lower endoscopy among older patients in the United States, 1998-2005.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Mayo Clin Proc; 2013 May; 88(5):464-70. PubMed ID: 23522751
[TBL] [Abstract][Full Text] [Related]
16. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial.
Atkin W; Wooldrage K; Parkin DM; Kralj-Hans I; MacRae E; Shah U; Duffy S; Cross AJ
Lancet; 2017 Apr; 389(10076):1299-1311. PubMed ID: 28236467
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
[TBL] [Abstract][Full Text] [Related]
18. Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program.
Paszat L; Sutradhar R; Tinmouth J; Baxter N; Rabeneck L
Can J Gastroenterol Hepatol; 2016; 2016():4768728. PubMed ID: 27446842
[TBL] [Abstract][Full Text] [Related]
19. Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.
Pinsky PF; Loberg M; Senore C; Wooldrage K; Atkin W; Bretthauer M; Cross AJ; Hoff G; Holme O; Kalager M; Segnan N; Schoen RE
Gastroenterology; 2018 Oct; 155(4):1059-1068.e2. PubMed ID: 29935150
[TBL] [Abstract][Full Text] [Related]
20. Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models.
Wieszczy P; Kaminski MF; Løberg M; Bugajski M; Bretthauer M; Kalager M
BMJ Open; 2021 Apr; 11(4):e042158. PubMed ID: 33853794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
